Multimodal deep learning approaches for precision oncology: a comprehensive review
Citations Over TimeTop 1% of 2024 papers
Abstract
The burgeoning accumulation of large-scale biomedical data in oncology, alongside significant strides in deep learning (DL) technologies, has established multimodal DL (MDL) as a cornerstone of precision oncology. This review provides an overview of MDL applications in this field, based on an extensive literature survey. In total, 651 articles published before September 2024 are included. We first outline publicly available multimodal datasets that support cancer research. Then, we discuss key DL training methods, data representation techniques, and fusion strategies for integrating multimodal data. The review also examines MDL applications in tumor segmentation, detection, diagnosis, prognosis, treatment selection, and therapy response monitoring. Finally, we critically assess the limitations of current approaches and propose directions for future research. By synthesizing current progress and identifying challenges, this review aims to guide future efforts in leveraging MDL to advance precision oncology.
Related Papers
- → Delivering precision oncology to patients with cancer(2022)342 cited
- → Addressing the challenges of applying precision oncology(2017)59 cited
- → PDX models for functional precision oncology and discovery science(2024)23 cited
- → Decision: Heterogeneity in precision oncology — R1/PR8(2023)
- → Implementation of Precision Oncology into the Diagnostic and Therapeutic Armamentarium: Actionable Takeaways from the 2023 Precision Oncology Summit(2024)